Profile for Ukraine Patent: 114075
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Ukraine Patent: 114075
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Jan 14, 2033 | Gilead Sciences Inc | COMPLERA | emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
